Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Department of Physiology, Anatomy & Genetics.

Frontal view of a developing mouse heart used in the study

The heart is the first organ to form during development and is critical for the survival of the embryo. The forming heart is very small, less than half a millimetre in width, and so far the precise molecular identity of the various cell types that make up the heart during these early stages have been poorly defined. However, recent years have seen rapid development in techniques which allow an unbiased assessment of molecular identity at the single cell level. Alongside this, advances in imaging technologies have now allowed researchers to visualise heart formation at high resolution and in real time.

In new research led by Department of Physiology, Anatomy & Genetics researcher Dr Richard Tyser and Dr Ximena Ibarra-Soria, the team combined these cutting-edge technologies to profile the molecular identity and precise locations of cells involved in the formation of the mouse embryonic heart. This allowed them to identify the earliest known progenitor of the epicardium, the outermost layer of the heart and an important source of signals and cells during cardiac development and injury.

The full story is available on the Department of Physiology, Anatomy & Genetics website

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.